Impairment of Antiviral Immune Response and Disruption of Cellular Functions by SARS-CoV-2 ORF7a and ORF7b

Overview

Journal iScience

Publisher Cell Press

Date 2022 Oct 31

PMID 36310646

Authors

Transito Garcia-Garcia

Raul Fernandez-Rodriguez

Natalia Redondo

Ana de Lucas-Rius

Sara Zaldivar-Lopez

Blanca Dies Lopez-Ayllon

Jose M Suarez-Cardenas

Angeles Jimenez-Marin

Maria Montoya

Juan J Garrido

Affiliations

Soon will be listed here.

Abstract

SARS-CoV-2, the causative agent of the present COVID-19 pandemic, possesses eleven accessory proteins encoded in its genome, and some have been implicated in facilitating infection and pathogenesis through their interaction with cellular components. Among these proteins, accessory protein ORF7a and ORF7b functions are poorly understood. In this study, A549 cells were transduced to express ORF7a and ORF7b, respectively, to explore more in depth the role of each accessory protein in the pathological manifestation leading to COVID-19. Bioinformatic analysis and integration of transcriptome results identified defined canonical pathways and functional groupings revealing that after expression of ORF7a or ORF7b, the lung cells are potentially altered to create conditions more favorable for SARS-CoV-2, by inhibiting the IFN-I response, increasing proinflammatory cytokines release, and altering cell metabolic activity and adhesion. Based on these results, it is plausible to suggest that ORF7a or ORF7b could be used as biomarkers of progression in this pandemic.

Citing Articles

Analysis of the structure and interactions of the SARS-CoV-2 ORF7b accessory protein.

Nguyen M, Palfy G, Fogeron M, Ninot Pedrosa M, Zehnder J, rimal V Proc Natl Acad Sci U S A. 2024; 121(46):e2407731121.

PMID: 39508769 PMC: 11573672. DOI: 10.1073/pnas.2407731121.

MDA5 Is a Major Determinant of Developing Symptoms in Critically Ill COVID-19 Patients.

Maiti A Clin Rev Allergy Immunol. 2024; 67(1-3):58-72.

PMID: 39460899 DOI: 10.1007/s12016-024-09008-z.

Evolution of the SARS-CoV-2 Omicron Variants: Genetic Impact on Viral Fitness.

Liu W, Huang Z, Xiao J, Wu Y, Xia N, Yuan Q Viruses. 2024; 16(2).

PMID: 38399960 PMC: 10893260. DOI: 10.3390/v16020184.

SARS-CoV-2 Accessory Protein Orf7b Induces Lung Injury via c-Myc Mediated Apoptosis and Ferroptosis.

Deshpande R, Li W, Li T, Fanning K, Clemens Z, Nyunoya T Int J Mol Sci. 2024; 25(2).

PMID: 38256231 PMC: 10816122. DOI: 10.3390/ijms25021157.

Analysis of SARS-CoV-2 genome evolutionary patterns.

Gupta S, Gupta D, Bhatnagar S Microbiol Spectr. 2024; 12(2):e0265423.

PMID: 38197644 PMC: 10846092. DOI: 10.1128/spectrum.02654-23.

References

Sa Ribero M, Jouvenet N, Dreux M, Nisole S . Interplay between SARS-CoV-2 and the type I interferon response. PLoS Pathog. 2020; 16(7):e1008737. PMC: 7390284. DOI: 10.1371/journal.ppat.1008737. View

Ellis P, Somogyvari F, Virok D, Noseda M, McLean G . Decoding Covid-19 with the SARS-CoV-2 Genome. Curr Genet Med Rep. 2021; 9(1):1-12. PMC: 7794078. DOI: 10.1007/s40142-020-00197-5. View

Jiang H, Zhang H, Meng Q, Xie J, Li Y, Chen H . SARS-CoV-2 Orf9b suppresses type I interferon responses by targeting TOM70. Cell Mol Immunol. 2020; 17(9):998-1000. PMC: 7387808. DOI: 10.1038/s41423-020-0514-8. View

Ma Y, Qin J, Plow E . Platelet integrin alpha(IIb)beta(3): activation mechanisms. J Thromb Haemost. 2007; 5(7):1345-52. DOI: 10.1111/j.1538-7836.2007.02537.x. View

Zost S, Gilchuk P, Case J, Binshtein E, Chen R, Nkolola J . Potently neutralizing and protective human antibodies against SARS-CoV-2. Nature. 2020; 584(7821):443-449. PMC: 7584396. DOI: 10.1038/s41586-020-2548-6. View

. The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2. Nat Microbiol. 2020; 5(4):536-544. PMC: 7095448. DOI: 10.1038/s41564-020-0695-z. View

Holland L, Kaelin E, Maqsood R, Estifanos B, Wu L, Varsani A . An 81-Nucleotide Deletion in SARS-CoV-2 ORF7a Identified from Sentinel Surveillance in Arizona (January to March 2020). J Virol. 2020; 94(14). PMC: 7343219. DOI: 10.1128/JVI.00711-20. View

Capuano A, Scavone C, Racagni G, Scaglione F . NSAIDs in patients with viral infections, including Covid-19: Victims or perpetrators?. Pharmacol Res. 2020; 157:104849. PMC: 7189871. DOI: 10.1016/j.phrs.2020.104849. View

Silvas J, Morales Vasquez D, Park J, Chiem K, Allue-Guardia A, Garcia-Vilanova A . Contribution of SARS-CoV-2 Accessory Proteins to Viral Pathogenicity in K18 Human ACE2 Transgenic Mice. J Virol. 2021; 95(17):e0040221. PMC: 8354228. DOI: 10.1128/JVI.00402-21. View

10.

Yount B, Roberts R, Sims A, Deming D, Frieman M, Sparks J . Severe acute respiratory syndrome coronavirus group-specific open reading frames encode nonessential functions for replication in cell cultures and mice. J Virol. 2005; 79(23):14909-22. PMC: 1287583. DOI: 10.1128/JVI.79.23.14909-14922.2005. View

11.

Redondo N, Zaldivar-Lopez S, Garrido J, Montoya M . SARS-CoV-2 Accessory Proteins in Viral Pathogenesis: Knowns and Unknowns. Front Immunol. 2021; 12:708264. PMC: 8293742. DOI: 10.3389/fimmu.2021.708264. View

12.

Liu M, Yang Y, Gu C, Yue Y, Wu K, Wu J . Spike protein of SARS-CoV stimulates cyclooxygenase-2 expression via both calcium-dependent and calcium-independent protein kinase C pathways. FASEB J. 2007; 21(7):1586-96. DOI: 10.1096/fj.06-6589com. View

13.

White D, Puranen S, Johnson M, Heino J . The collagen receptor subfamily of the integrins. Int J Biochem Cell Biol. 2004; 36(8):1405-10. DOI: 10.1016/j.biocel.2003.08.016. View

14.

Batah S, Fabro A . Pulmonary pathology of ARDS in COVID-19: A pathological review for clinicians. Respir Med. 2020; 176:106239. PMC: 7674971. DOI: 10.1016/j.rmed.2020.106239. View

15.

De Filippo K, Dudeck A, Hasenberg M, Nye E, van Rooijen N, Hartmann K . Mast cell and macrophage chemokines CXCL1/CXCL2 control the early stage of neutrophil recruitment during tissue inflammation. Blood. 2013; 121(24):4930-7. DOI: 10.1182/blood-2013-02-486217. View

16.

Lee S, Cheung C, Nicholls J, Hui K, Leung C, Uiprasertkul M . Hyperinduction of cyclooxygenase-2-mediated proinflammatory cascade: a mechanism for the pathogenesis of avian influenza H5N1 infection. J Infect Dis. 2008; 198(4):525-35. DOI: 10.1086/590499. View

17.

Li H, Zhang J, Fang C, Zhao X, Qian B, Sun Y . The prognostic value of IL-8 for the death of severe or critical patients with COVID-19. Medicine (Baltimore). 2021; 100(11):e23656. PMC: 7982189. DOI: 10.1097/MD.0000000000023656. View

18.

Sumigray K, Lechler T . Cell adhesion in epidermal development and barrier formation. Curr Top Dev Biol. 2015; 112:383-414. PMC: 4737682. DOI: 10.1016/bs.ctdb.2014.11.027. View

19.

Ericson J, Duffau P, Yasuda K, Ortiz-Lopez A, Rothamel K, Rifkin I . Gene expression during the generation and activation of mouse neutrophils: implication of novel functional and regulatory pathways. PLoS One. 2014; 9(10):e108553. PMC: 4184787. DOI: 10.1371/journal.pone.0108553. View

20.

Zhang J, Cruz-Cosme R, Zhuang M, Liu D, Liu Y, Teng S . A systemic and molecular study of subcellular localization of SARS-CoV-2 proteins. Signal Transduct Target Ther. 2020; 5(1):269. PMC: 7670843. DOI: 10.1038/s41392-020-00372-8. View